D-0237-2024 Class II Ongoing

Recalled by Ascend Laboratories, LLC — Parsippany, NJ

FDA drug recall D-0237-2024 was initiated by Ascend Laboratories, LLC on Dec 29, 2023 and is designated Class II. Reason for recall: Presence of Foreign Tablet/Capsule: A stray Rasagiline Mesylate 1 mg tablet was discovered in an unopened bottle of Ibuprofen and Famotidine. The recall status is ongoing. Affected quantity: 3,288 bottles.

Recall details

Product Type
Drugs
Report Date
Jan 24, 2024
Initiation Date
Dec 29, 2023
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
3,288 bottles

Product description

Ibuprofen and Famotidine Tablets 800mg/26.6mg, Rx Only, 90 Tablets per Bottle, manufactured by: Alkem Laboratories Ltd., INDIA, Distributed by: Ascend Laboratories, LLC., Parsippany, NJ 07054, NDC 67877-626-90

Reason for recall

Presence of Foreign Tablet/Capsule: A stray Rasagiline Mesylate 1 mg tablet was discovered in an unopened bottle of Ibuprofen and Famotidine.

Distribution pattern

Nationwide

Code information

23140190, Exp. Date 12/31/2024

Source

Dataset
openFDA drug recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for D-0237-2024
openFDA file date
Nov 10, 2026
Loaded by RegDataLab
Nov 11, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Source: openFDA record for D-0237-2024. Report a data issue: hello@regdatalab.com.